Results 161 to 170 of about 48,965 (195)
Some of the next articles are maybe not open access.

Mechanisms of HIV persistence in HIV reservoirs

Reviews in Medical Virology, 2017
SummaryThe establishment and maintenance of HIV reservoirs that lead to persistent viremia in patients on antiretroviral drugs remains the greatest challenge of the highly active antiretroviral therapy era. Cellular reservoirs include resting memory CD4+ T lymphocytes, implicated as the major HIV reservoir, having a half‐life of approximately 44 months
Mayibongwe L. Mzingwane   +1 more
openaire   +3 more sources

Astrocytes as an HIV Reservoir: Mechanism of HIV Infection

Current HIV Research, 2016
If we have any hope of achieving a cure for HIV infection, close attention to the cell types capable of getting infected with HIV is necessary. Of these cell types, astrocytes are the most ideal cell type for the formation of such a reservoir. These are long-lived cells with a very low turnover rate and are found in the brain and the gastrointestinal ...
Guan-Han, Li   +2 more
openaire   +2 more sources

Phylogenies in ART: HIV reservoirs, HIV latency and drug resistance

Current Opinion in Pharmacology, 2019
Combination antiretroviral therapy (ART) has significantly reduced the morbidity and mortality resulting from HIV infection. ART is, however, unable to eradicate HIV, which persists latently in several cell types and tissues. Phylogenetic analyses suggested that the proliferation of cells infected before ART initiation is mainly responsible for ...
Bandera A.   +3 more
openaire   +4 more sources

HIV DNA

Current Opinion in HIV and AIDS, 2018
A number studies are currently underway to develop new drugs aimed at reducing the HIV reservoir or achieving ART-free control of HIV infection. Many markers of HIV reservoirs have been proposed, each one having a different meaning. Total HIV DNA dynamics during the course of HIV infection and its predictive value are now well known.
Christine, Rouzioux   +2 more
openaire   +2 more sources

Viral reservoirs and HIV-specific immunity

Current Opinion in Internal Medicine, 2006
HIV-1 infection is complicated by the presence of latently infected CD4 T cells as well as several anatomical reservoirs that present a barrier to eradication by current antiretroviral therapy. The early establishment of these reservoirs also presents a challenge to the development of preventive vaccines.
openaire   +2 more sources

A new latent HIV reservoir

Nature Medicine, 2001
The persistence of latently infected T cells is a major hurdle to eradication of HIV by antiviral therapy. It now seems that HIV latency can occur during normal T-cell differentiation in the thymus, and is regulated by the overall state of cellular gene transcription (pages 459–464 ).
openaire   +1 more source

Eliminating HIV-1 reservoirs.

Current opinion in investigational drugs (London, England : 2000), 2003
HIV-1 infection can now be treated effectively in many patients in the developed world, using combination antiretroviral therapeutics, called highly active antiretroviral therapy (HAART). Nevertheless, these regimens do not cure HIV-1 infection. Residual disease is maintained via proviral latency in resting CD4+ T-lymphocytes and possibly monocytes ...
openaire   +1 more source

Cervical cancer prevention and control in women living with human immunodeficiency virus

Ca-A Cancer Journal for Clinicians, 2021
Philip E Castle, Vikrant V Sahasrabuddhe
exaly  

Prevention, treatment and cure of HIV infection

Nature Reviews Microbiology, 2023
Raphael J Landovitz   +2 more
exaly  

Home - About - Disclaimer - Privacy